Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 4
2013 5
2014 4
2015 12
2016 10
2017 18
2018 20
2019 14
2020 13
2021 10
2022 7
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 29225988

103 results

Results by year

Filters applied: . Clear all
Page 1
Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease：A case report.
Kagawa H, Tsujino K, Yamamoto Y, Iwai A, Hara R, Matsuki T, Fukushima K, Oshitani Y, Yoshimura K, Miki M, Miki K, Kitada S, Mori M, Kida H. Kagawa H, et al. Respir Med Case Rep. 2020 Feb 1;29:101016. doi: 10.1016/j.rmcr.2020.101016. eCollection 2020. Respir Med Case Rep. 2020. PMID: 32055439 Free PMC article.
Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, Okamoto Y, Hamaguchi Y, Murakami A, Hasegawa M, Kuwana M, Fujimoto M, Takehara K. Matsushita T, et al. Br J Dermatol. 2017 Feb;176(2):395-402. doi: 10.1111/bjd.14882. Epub 2017 Jan 19. Br J Dermatol. 2017. PMID: 27452897
Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
Sakamoto S, Okamoto M, Kaieda S, Fujimoto K, Nagata S, Tominaga M, Nakamura M, Zaizen Y, Nouno T, Koga T, Kawayama T, Kuwana M, Ida H, Hoshino T. Sakamoto S, et al. Respir Investig. 2018 Nov;56(6):464-472. doi: 10.1016/j.resinv.2018.07.007. Epub 2018 Aug 24. Respir Investig. 2018. PMID: 30150008
103 results